1217117

Astellas Pharma US Inc. — FEI 1000036852

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 14, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Northbrook, IL (United States)

Additional Details

Sponsor, Contract Research Organization